• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Cancer Biologic Therapy Companies

    ID: MRFR/Pharma/0123-CR
    128 Pages
    Kinjoll Dey
    June 2017

    Biological therapy, also known as immunotherapy, is a type of cancer treatment that uses the body's immune system to target and destroy cancer cells. Companies involved in global cancer biological therapy operate in the biotechnology and pharmaceutical sectors. They develop and manufacture biologically derived products, such as monoclonal antibodies, immune checkpoint inhibitors, and other immunotherapeutic agents, to treat various types of cancer.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Cancer Biologic Therapy Market

    Cancer Biological Therapy Companies

    Latest Cancer Biological Therapy Companies Update



    Bristol Myers Squibb (US) acquires Turning Point Therapeutics (US) for $3.2 billion, gaining access to TP-598, a promising T-cell receptor therapy for solid tumors. (Jan 2024)


    Roche (Switzerland) announces plans to purchase biotech company ImmunoGen (US) for $5.8 billion, strengthening its portfolio of antibody-drug conjugates for cancer treatment. (Dec 2023)


    Pfizer (US) acquires cell therapy developer Vivant Biosciences (US) for $2.5 billion, aiming to expand its offerings in CAR-T cell therapy. (Nov 2023)


    AstraZeneca (UK) receives FDA approval for Imfinzi (durvalumab) for the treatment of non-small cell lung cancer in combination with chemotherapy. (Jan 2024)


    Merck & Co. (US) launches Keytruda (pembrolizumab) for the first-line treatment of advanced head and neck cancer. (Dec 2023)


    Johnson & Johnson (US) unveils Tecentriq (atezolizumab) for the treatment of triple-negative breast cancer in combination with chemotherapy. (Nov 2023)


    List of Cancer Biological Therapy companies in the market

    • Amgen Inc.

    • Bristol-Myers Squibb

    • Celgene Corporation

    • ELI Lilly and Company

    • Hoffmann-La Roche AG

    • EnGeneIC Ltd

    • Merck & Co. Inc.

    • Novartis, Pfizer Inc.